Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07325292
Recruiting
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Phase 3 · Austria, Belgium, Bulgaria, Brazil, China, Czechia, Germany, Denmark, Spain, France, Greece, Hungary, Italy, Japan, Lithuania, Netherlands, Poland, Portugal, Sweden, Slovakia, United States · 173 sites
Registry update: 13 Oct 2026
NCT07441941
Recruiting
Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup
Not applicable · France · 2 sites
Registry update: 2 Mar 2026
NCT07135752
Recruiting
Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination
Not applicable · France · 1 site
Registry update: 21 Jan 2026
NCT07831993
Recruiting
Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract Cancer
Phase 2 · China · 1 site
Registry update: 21 Sept 2026
NCT07324824
Recruiting
Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma
Phase 2 · China · 1 site
Registry update: 16 Jan 2026
NCT07089121
Recruiting
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Phase 1/2 · United States · 3 sites
Registry update: 27 Jul 2026
NCT06980480
Recruiting
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Phase 3 · Austria, Australia, Brazil, Canada, Czechia, Germany, Denmark, Spain, United Kingdom, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Romania, United States · 76 sites
Registry update: 13 Oct 2026
NCT07319871
Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Phase 1 · United Kingdom, United States · 5 sites
Registry update: 3 Nov 2026
NCT07170176
Recruiting
Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine
Not applicable · China · 2 sites
Registry update: 16 Jan 2026
NCT07335042
Recruiting
Prediction Model for MINS After Major Hepatobiliary Surgery
Not applicable · China · 6 sites
Registry update: 15 Jun 2026
2025-522495-84-00
Recruiting
A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)
Phase 1/2 · Spain · 3 sites
Registry update: 3 Nov 2026
NCT07098975
Recruiting
Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)
Phase 2 · Spain · 2 sites
Registry update: 16 Oct 2026
2025-520913-29-00
Recruiting
CO2MO
Phase 4 · Netherlands · 2 sites
Registry update: 25 Jul 2025
NCT07249372
Recruiting
DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer
Phase 2 · United States · 2 sites
Registry update: 26 May 2026
NCT06733363
Recruiting
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Phase 2 · United States · 1 site
Registry update: 17 Sept 2026
NCT07216209
Recruiting
The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
Not applicable · United States · 1 site
Registry update: 21 Apr 2026
NCT07146854
Recruiting
EndoForce Post Approval Study
Not applicable · United States · 2 sites
Registry update: 21 Jan 2026
NCT07623850
Recruiting
A Phase I Study of JLM019 Injection
Phase 1 · China · 1 site
Registry update: 3 Jun 2026
NCT07723872
Recruiting
Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease
Not applicable · Spain · 1 site
Registry update: 23 Jul 2026
NCT07245745
Recruiting
Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer
Not applicable · Belgium · 1 site
Registry update: 16 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.